TRENTON, N.J. - Closing another chapter in the painful saga over withdrawn arthritis pill Vioxx, Merck & Co. has agreed to settle lawsuits brought by shareholders who lost billions, by appointing two committees and a chief medical officer to monitor drug safety and keep the company honest.
via boston.com
Dr Michael Rosenblatt (pic), ex dean of Tufts University School of Medicine, is Merck's new CMO.
No comments:
Post a Comment